Acute Kidney Injury Among Patients with Multi-Drug Resistant Infection: A Study from Jordan

References

• Santos RPD, Carvalho ARS, Peres LAB, Ronco C, Macedo E. An epidemiologic overview of acute kidney injury in intensive care units. Rev Assoc Med Bras. 2019;65(8):1094–1101. doi:10.1590/1806-9282.65.8.1094
   PubMed Web of Science ®Google Scholar
• Rachoin JS, Weisberg LS. Renal replacement therapy in the ICU. Crit Care Med. 2019;47(5):715–721. doi:10.1097/CCM.0000000000003701
   PubMed Web of Science ®Google Scholar
• Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics. 2020;9(4):196. doi:10.3390/antibiotics9040196
   Web of Science ®Google Scholar
• Goyal A, Daneshpajouhnejad P, Bashir K. Acute kidney injury (acute renal failure). In: StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2019.
   Google Scholar
• Ulger F, Pehlivanlar Kucuk M, Kucuk AO, et al. Evaluation of acute kidney injury (AKI) with RIFLE, AKIN, CK, and KDIGO in critically ill trauma patients. Eur J Trauma Emerg Surg. 2018;44(4):597–605. doi:10.1007/s00068-017-0820-8
   PubMed Web of Science ®Google Scholar
• Oweis AO, Alshelleh SA, Momany SM, Samrah SM, Khassawneh BY, Al Ali MAK. Incidence, risk factors, and outcome of acute kidney injury in the intensive care unit: a single-center study from Jordan. Crit Care Res Pract. 2020;2020:8753764. doi:10.1155/2020/8753764
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Rule AD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron. 2016;134(1):25–29. doi:10.1159/000445450
   PubMed Web of Science ®Google Scholar
• Del Giudice A, Aucella F. Acute renal failure in the elderly: epidemiology and clinical features. J Nephrol. 2012;25(Suppl 19):S48–S57. doi:10.5301/jn.5000141
   PubMed Web of Science ®Google Scholar
• Himmelfarb J. Acute kidney injury in the elderly: problems and prospects. Semin Nephrol. 2009;29(6):658–664. doi:10.1016/j.semnephrol.2009.07.008
   PubMed Web of Science ®Google Scholar
• Oweis AO, Alshelleh SA. Incidence and outcomes of acute kidney injury in octogenarians in Jordan. BMC Res Notes. 2018;11(1):279. doi:10.1186/s13104-018-3397-3
   PubMedGoogle Scholar
• Alshelleh SA, Oweis AO, Alzoubi KH. Acute kidney injury among nonagenarians in Jordan: a retrospective case-control study. Int J Nephrol Renovasc Dis. 2018;11:337–342. doi:10.2147/IJNRD.S186121
   PubMed Web of Science ®Google Scholar
• Loutradis C, Pickup L, Law JP, et al. Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history. Biol Sex Differ. 2021;12(1):30. doi:10.1186/s13293-021-00373-4
   PubMed Web of Science ®Google Scholar
• Yun D, Choi Y, Lee SP, et al. Blood pressure and renal progression in patients undergoing percutaneous coronary intervention. Am J Hypertens. 2020;33:676–684. doi:10.1093/ajh/hpaa046
   PubMed Web of Science ®Google Scholar
• Jiang YJ, Xi XM, Jia HM, et al. Risk factors, clinical features and outcome of new-onset acute kidney injury among critically ill patients: a database analysis based on prospective cohort study. BMC Nephrol. 2021;22(1):289. doi:10.1186/s12882-021-02503-x
   PubMed Web of Science ®Google Scholar
• Bobbili RK, Deepanjali S, Rajesh NG, Ramesh A, Medha R. Acute kidney injury in patients hospitalized with febrile urinary tract infections: a prospective observational study. Clin Nephrol. 2021;95(3):127–135. doi:10.5414/CN110229
   PubMed Web of Science ®Google Scholar
• Garcia-Bustos V, Escrig AIR, López CC, et al. Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance. Sci Rep. 2021;11(1):11927. doi:10.1038/s41598-021-90949-2
   PubMed Web of Science ®Google Scholar
• Rubin S, Orieux A, Clouzeau B, et al. The incidence of chronic kidney disease three years after non-severe acute kidney injury in critically ill patients: a single-center cohort study. J Clin Med. 2019;8:12. doi:10.3390/jcm8122215
   Web of Science ®Google Scholar
• Pinheiro KHE, Azedo FA, Areco KCN, Laranja SMR. Risk factors and mortality in patients with sepsis, septic and non septic acute kidney injury in ICU. J Brasileiro De Nefrologia. 2019;41:462–471. doi:10.1590/2175-8239-jbn-2018-0240
   PubMedGoogle Scholar
• Hounkpatin HO, Fraser SDS, Glidewell L, Blakeman T, Lewington A, Roderick PJ. Predicting risk of recurrent acute kidney injury: a systematic review. Nephron. 2019;142(2):83–90. doi:10.1159/000497385
   PubMed Web of Science ®Google Scholar
• Sohaney R, Heung M. Care of the survivor of critical illness and acute kidney injury: a multidisciplinary approach. Adv Chronic Kidney Dis. 2021;28(1):105–113. doi:10.1053/j.ackd.2021.01.001
   PubMed Web of Science ®Google Scholar
• Zhang Q, Fei Y, Jiang L. [Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(2):155–159. [ Chinese]. doi:10.3760/cma.j.issn.2095-4352.2019.02.007
   PubMedGoogle Scholar
• Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43(6):855–866. doi:10.1007/s00134-017-4809-x
   PubMed Web of Science ®Google Scholar
• Ballouz T, Zeenny RM, Haddad N, Rizk N, Kanj SS. Retrospective evaluation of intravenous fosfomycin in multi-drug resistant infections at a tertiary care hospital in Lebanon. J Infect Dev Ctries. 2021;15(9):1308–1313. doi:10.3855/jidc.14125
   PubMed Web of Science ®Google Scholar
• Mitaka H, Gomez T, Lee YI, Perlman DC. Risk Factors for positive follow-up blood cultures in gram-negative bacilli bacteremia: implications for selecting who needs follow-up blood cultures. Open Forum Infect Dis. 2020;7(4):ofaa110. doi:10.1093/ofid/ofaa110
   PubMed Web of Science ®Google Scholar
• Meschiari M, Orlando G, Kaleci S, et al. Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) pseudomonas aeruginosa: resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs. Antibiotics. 2021;10(10):1224.
   Web of Science ®Google Scholar
• Wani FA, Bandy A, Alenzi MJS, et al. Resistance patterns of gram-negative bacteria recovered from clinical specimens of intensive care patients. Microorganisms. 2021;9:11. doi:10.3390/microorganisms9112246
   Web of Science ®Google Scholar
• Siritip N, Nongnuch A, Dajsakdipon T, Thongprayoon C, Cheungprasitporn W, Bruminhent J. Epidemiology, risk factors, and outcome of bloodstream infection within the first year after kidney transplantation. Am J Med Sci. 2021;361(3):352–357. doi:10.1016/j.amjms.2020.10.011
   PubMed Web of Science ®Google Scholar
• Lin TL, Chang PH, Chen IL, et al. Risk factors and mortality associated with multidrug-resistant gram-negative bacterial infection in adult patients with abdominal surgery. J Hosp Infect. 2021;119:22–32. doi:10.1016/j.jhin.2021.09.021
   PubMed Web of Science ®Google Scholar
• Huertas Vaquero M, Asencio Egea MA, Carranza González R, et al. Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis. Rev Esp Quimioter. 2021;34:623–630. doi:10.37201/req/061.2021
   PubMed Web of Science ®Google Scholar
• Su Guobin, Xu H, Riggi E, et al. Association of kidney function with infections by multidrug-resistant organisms: an electronic medical record analysis. Sci Rep. 2018;8(1):13372. doi:10.1038/s41598-018-31612-1
   PubMed Web of Science ®Google Scholar
• Torres RT, Cunha MV, Araujo D, Ferreira H, Fonseca C, Palmeira JD. Emergence of colistin resistance genes (mcr-1) in Escherichia coli among widely distributed wild ungulates. Environ Pollut. 2021;291:118136. doi:10.1016/j.envpol.2021.118136
   PubMed Web of Science ®Google Scholar
• Spinler JK, Raza S, Thapa S, et al. Comparison of whole genome sequencing and repetitive element PCR for multidrug- resistant pseudomonas aeruginosa strain typing. J Mol Diagn. 2021;24:158–166. doi:10.1016/j.jmoldx.2021.10.004
   PubMed Web of Science ®Google Scholar
• Mitra SD, Irshad P, Anusree M, et al. Whole genome global insight of antibiotic resistance gene repertoire and virulome of high - risk multidrug-resistant Uropathogenic Escherichia coli. Microb Pathog. 2021;161(Pt A):105256. doi:10.1016/j.micpath.2021.105256
   PubMed Web of Science ®Google Scholar
• Sisay M, Hagos B, Edessa D, Tadiwos Y, Mekuria AN. Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury. Pharmacol Res. 2021;163:105328. doi:10.1016/j.phrs.2020.105328
   PubMed Web of Science ®Google Scholar
• Oda K, Hashiguchi Y, Katanoda T, Nakata H, Jono H, Saito H. Lowered risk of nephrotoxicity through intervention against the combined use of vancomycin and tazobactam/piperacillin: a retrospective cohort study. Microbiol Spectr. 2021;9(1):e0035521. doi:10.1128/Spectrum.00355-21
   PubMed Web of Science ®Google Scholar
• Elliott BP, Tang MM, Madden JA, et al. A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime. Intern Emerg Med. 2021;16:1–9. doi:10.1007/s11739-020-02494-x
   PubMed Web of Science ®Google Scholar
• Aitullina A, Purviņa S, Krūmiņa A. Colistin co-administration with other nephrotoxins: experience of teaching hospital of Latvia. Int J Clin Pharm. 2021;43(3):509–517. doi:10.1007/s11096-020-01154-6
   PubMed Web of Science ®Google Scholar
• Vauchel T, Pirracchio R, Chaussard M, et al. Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: a targeted machine learning analysis. Am J Infect Control. 2019;47(4):435–438. doi:10.1016/j.ajic.2018.09.010
   PubMed Web of Science ®Google Scholar
• Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, Nji E. Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis. Glob Health Action. 2019;12(sup1):1815272. doi:10.1080/16549716.2020.1815272
   PubMed Web of Science ®Google Scholar
• Khademi F, Sahebkar A. Is penicillin-nonsusceptible streptococcus pneumoniae a significant challenge to healthcare system? A systematic review and meta-analysis. Scientifica. 2021;2021:5573345. doi:10.1155/2021/5573345
   PubMed Web of Science ®Google Scholar
• Neut C. Carriage of multidrug-resistant bacteria in healthy people: recognition of several risk groups. Antibiotics. 2021;10:10. doi:10.3390/antibiotics10101163
   Web of Science ®Google Scholar
• Henderson HI, Napravnik S, Gower EW, et al. Resistance in Enterobacterales is higher among people with HIV. Clin Infect Dis. 2021;75:28–34.
   Web of Science ®Google Scholar
• Guclu E, Halis F, Kose E, Ogutlu A, Karabay O. Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections. Afr Health Sci. 2021;21(1):214–219. doi:10.4314/ahs.v21i1.28
   PubMed Web of Science ®Google Scholar
• Ferreira CM, Filho R, Ferreira GMA, et al. Molecular epidemiology of methicillin resistant Staphylococcus species in healthcare workers of a blood bank in the Brazilian Amazon. BMC Microbiol. 2021;21(1):306. doi:10.1186/s12866-021-02365-1
   PubMed Web of Science ®Google Scholar
• Atamna-Mawassi H, Huberman-Samuel M, Hershcovitz S, et al. Interventions to reduce infections caused by multidrug resistant Enterobacteriaceae (MDR-E): a systematic review and meta-analysis. J Infect. 2021;83(2):156–166. doi:10.1016/j.jinf.2021.05.005
   PubMed Web of Science ®Google Scholar
• Abdul-Mutakabbir JC, Griffith NC, Shields RK, Tverdek FP, Escobar ZK. Contemporary perspective on the treatment of Acinetobacter baumannii infections: insights from the society of infectious diseases pharmacists. Infect Dis Ther. 2021;10(4):2177–2202. doi:10.1007/s40121-021-00541-4
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Zhang JS, Qiao L. The Acinetobacter baumannii group: a systemic review. World J Emerg Med. 2013;4(3):169–174. doi:10.5847/wjem.j.issn.1920-8642.2013.03.002
   PubMedGoogle Scholar
• Jin H, Qiu F, Ji HJ, Lu Q. Analysis of drug resistance in 1861 strains of Acinetobacter baumannii. Biomed Rep. 2016;4(4):463–466. doi:10.3892/br.2016.598
   PubMedGoogle Scholar
• Shi J, Sun T, Cui Y, et al. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis. 2020;20(1):597. doi:10.1186/s12879-020-05321-y
   PubMed Web of Science ®Google Scholar
• Huang Y, Gong C, Fu J, et al. [Analysis of prognostic risk factors of bloodstream infection in intensive care unit patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(12):1440–1444. Chinese. doi:10.3760/cma.j.cn121430-20201016-00675
   PubMedGoogle Scholar